These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1674259)
41. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. Bloom BS; Fendrick AM; Chernew ME; Patel P Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629 [TBL] [Abstract][Full Text] [Related]
42. [Carriers of Staphylococcus aureus as a source of nosocomial infections. Epidemiological and prophylactic aspects]. Kolmos HJ Ugeskr Laeger; 1999 Mar; 161(11):1580-4. PubMed ID: 10202440 [TBL] [Abstract][Full Text] [Related]
43. Nasal carriage of MRSA: the role of mupirocin and outlook for resistance. Hill RL; Casewell MW Drugs Exp Clin Res; 1990; 16(8):397-402. PubMed ID: 2129029 [TBL] [Abstract][Full Text] [Related]
44. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Herwaldt LA; Cullen JJ; French P; Hu J; Pfaller MA; Wenzel RP; Perl TM Infect Control Hosp Epidemiol; 2004 Jun; 25(6):481-4. PubMed ID: 15242196 [TBL] [Abstract][Full Text] [Related]
45. Mupirocin treatment of nasal staphylococcal colonization. Scully BE; Briones F; Gu JW; Neu HC Arch Intern Med; 1992 Feb; 152(2):353-6. PubMed ID: 1739366 [TBL] [Abstract][Full Text] [Related]
46. Mupirocin Resistance in Isolates of Staphylococcus spp. from Nasal Swabs in a Tertiary Hospital in France. Trouillet-Assant S; Flammier S; Sapin A; Dupieux C; Dumitrescu O; Tristan A; Vandenesch F; Rasigade JP; Laurent F J Clin Microbiol; 2015 Aug; 53(8):2713-5. PubMed ID: 26019208 [TBL] [Abstract][Full Text] [Related]
47. Nasal carriage of Staphylococcus aureus in patients undergoing Mohs micrographic surgery is an important risk factor for postoperative surgical site infection: a prospective randomised study. Tai YJ; Borchard KL; Gunson TH; Smith HR; Vinciullo C Australas J Dermatol; 2013 May; 54(2):109-14. PubMed ID: 23425142 [TBL] [Abstract][Full Text] [Related]
48. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Kalmeijer MD; Coertjens H; van Nieuwland-Bollen PM; Bogaers-Hofman D; de Baere GA; Stuurman A; van Belkum A; Kluytmans JA Clin Infect Dis; 2002 Aug; 35(4):353-8. PubMed ID: 12145715 [TBL] [Abstract][Full Text] [Related]
49. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections]. García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556 [TBL] [Abstract][Full Text] [Related]
50. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Laupland KB; Conly JM Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405 [TBL] [Abstract][Full Text] [Related]
51. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients. Souly K; Ait el kadi M; Lahmadi K; Biougnach H; Boughaidi A; Zouhdi M; Benasila S; Elyoussefi Z; Bouattar T; Zbiti N; Skalli Z; Rhou H; Ouzeddoun N; Bayahia R; Benamar L Med Mal Infect; 2011 Sep; 41(9):469-74. PubMed ID: 21752563 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of nasal Staphylococcus aureus eradication by topical nasal mupirocin in patients with perennial allergic rhinitis. Zeldin Y; Weiler Z; Cohen A; Kalinin M; Schlesinger M; Kidon M; Magen E Ann Allergy Asthma Immunol; 2008 Jun; 100(6):608-11. PubMed ID: 18592827 [TBL] [Abstract][Full Text] [Related]
53. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa. Moy JA; Caldwell-Brown D; Lin AN; Pappa KA; Carter DM J Am Acad Dermatol; 1990 May; 22(5 Pt 1):893-5. PubMed ID: 2112168 [TBL] [Abstract][Full Text] [Related]
54. Determinants of Staphylococcus aureus nasal carriage. Nouwen JL; van Belkum A; Verbrugh HA Neth J Med; 2001 Sep; 59(3):126-33. PubMed ID: 11583828 [TBL] [Abstract][Full Text] [Related]
55. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Kluytmans JA; Wertheim HF Infection; 2005 Feb; 33(1):3-8. PubMed ID: 15750752 [TBL] [Abstract][Full Text] [Related]
56. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. Martin JN; Perdreau-Remington F; Kartalija M; Pasi OG; Webb M; Gerberding JL; Chambers HF; Täuber MG; Lee BL J Infect Dis; 1999 Sep; 180(3):896-9. PubMed ID: 10438389 [TBL] [Abstract][Full Text] [Related]
57. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. Hill RL; Duckworth GJ; Casewell MW J Antimicrob Chemother; 1988 Sep; 22(3):377-84. PubMed ID: 3141347 [TBL] [Abstract][Full Text] [Related]
58. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630 [TBL] [Abstract][Full Text] [Related]
59. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial. Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727 [TBL] [Abstract][Full Text] [Related]